| 國立成功大學 |
2023 |
Efficient estimation of a Cox model when integrating the subgroup incidence rate information
|
Su, P.-F.;Zhong, J.;Liu, Y.-C.;Lin, T.-H.;Ou, H.-T. |
| 臺大學術典藏 |
2022-01-25T08:15:19Z |
Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials
|
Chen Y.-C.; Yoo D.H.; Lee C.K.; KO-JEN LI; Won J.-E.; Wu W.-S.; Zhong J.; Nicolay C.; Walls C.D.; Tanaka Y. |
| 國立成功大學 |
2022 |
Efficient estimation of a Cox model when integrating the subgroup incidence rate information
|
Su, P.-F.;Zhong, J.;Liu, Y.-C.;Lin, T.-H.;Ou, H.-T. |
| 國立成功大學 |
2022 |
Simultaneous tests of non inferiority and superiority in three-arm clinical studies with heterogeneous variance
|
Zhong, J.;Wen, M.-J.;Cheung, S.H.;Poon, W.-Y. |
| 國立成功大學 |
2021 |
Meteorological and Electrical Conditions of Two Mid-latitude Thunderstorms Producing Blue Discharges
|
Liu, F.;Zhu, B.;Lu, G.;Lei, J.;Shao, J.;Chen, Y.;Huang, A.;Ma, Ma M.;Qin, Z.;Zhong, J.;Ren, H.;Wang, Z.;Wan, Z.;Liu, G.;Peng, C.;Peng, K.-M.;Zhou, H. |
| 國立成功大學 |
2021 |
Bayesian two-stage design for drug screening trials with switching hypothesis tests based on continuous endpoints
|
Sun, N.;Zhong, J.;Wen, M.-J. |
| 臺大學術典藏 |
2020-10-20T01:45:46Z |
TSLP signaling network revealed by SILAC-based phosphoproteomics
|
Pandey A.; Tyner J.W.; Zhong J.; Kim M.-S.; Chaerkady R.; Wu X.; TAI-CHUNG HUANG; Getnet D.; Mitchell C.J.; Palapetta S.M.; Sharma J.; O'Meally R.N.; Cole R.N.; Yoda A.; Moritz A.; Loriaux M.M.; Rush J.; Weinstock D.M. |
| 臺大學術典藏 |
2020-10-20T01:45:45Z |
TSLP signaling pathway map: A platform for analysis of TSLP-mediated signaling
|
Zhong J.; Sharma J.; Raju R.; Palapetta S.M.; Prasad T.S.K.; TAI-CHUNG HUANG; Yoda A.; Tyner J.W.; Van Bodegom D.; Weinstock D.M.; Ziegler S.F.; Pandey A. |
| 臺大學術典藏 |
2020-10-20T01:45:45Z |
A draft map of the human proteome
|
Nanjappa V.; Radhakrishnan A.; Prasad S.; Subbannayya T.; Raju R.; Kumar M.; Sreenivasamurthy S.K.; Marimuthu A.; Sathe G.J.; Chavan S.; Datta K.K.; Subbannayya Y.; Sahu A.; Yelamanchi S.D.; Jayaram S.; Rajagopalan P.; Sharma J.; Murthy K.R.; Syed N.; Goel R.; Khan A.A.; Ahmad S.; Dey G.; Mudgal K.; Chatterjee A.; TAI-CHUNG HUANG; Zhong J.; Wu X.; Shaw P.G.; Freed D.; Zahari M.S.; Mukherjee K.K.; Shankar S.; Patil A.H.; Selvan L.D.N.; Renuse S.; Advani J.; George B.; Sahasrabuddhe N.A.; Balakrishnan L.; Kumar P.; Leal-Rojas P.; Muthusamy B.; Thomas J.K.; Jain S.; Isserlin R.; Kelkar D.S.; Madugundu A.K.; Chaerkady R.; Manda S.S.; Nirujogi R.S.; Getnet D.; Pinto S.M.; Kim M.-S.; Pandey A.; Gowda H.; Bader G.D.; Iacobuzio-Donahue C.A.; Mahadevan A.; Lam H.; Mitchell C.J.; Shankar S.K.; Satishchandra P.; Schroeder J.T.; Sirdeshmukh R.; Maitra A.; Leach S.D.; Drake C.G.; Halushka M.K.; Prasad T.S.K.; Hruban R.H.; Kerr C.L. |
| 臺大學術典藏 |
2020-10-20T01:45:44Z |
Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target
|
Pandey A.; Civin C.; Gojo I.; Tyner J.; Weinstock D.; Zhong J.; Bharne S.; Cutler J.; TAI-CHUNG HUANG |
